Buy & Sell American Tower Corp (AMT) – American Tower Corp Price Today
Study shows 1 in 7 patients switch back to Humira after moving to biosimilars post-formulary changes
A new study analyzing nearly 68,000 US patients found that adoption of adalimumab biosimilars increased significantly after formulary changes, but over 16% of those who switched from Humira reverted back to the original drug. The research highlights ...
Biogen shareholders to receive $18.9M in proposed class action settlement for stock purchases in 2021
A proposed $18.9 million class action settlement has been approved by a U.S. District Court for investors who purchased Biogen Inc. common stock between June 8 and July 12, 2021. The settlement aims to resolve claims against Biogen and certain execut...
Caribou Biosciences CEO to speak at H.C. Wainwright Cell Therapy Conference June 30, 2026
Caribou Biosciences, a clinical-stage CRISPR biopharma company, announced that CEO Rachel Haurwitz will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30, 2026. The event highlights Caribou's ...
Kaltura named Representative Vendor in 2026 Gartner Market Guide for Video Platform Services
Kaltura has been recognized as a Representative Vendor in the 2026 Gartner Market Guide for Video Platform Services for the second consecutive year. The company offers AI-driven video platform services that transform video into interactive, intellige...
Elicio Therapeutics joins Russell 2000 and 3000 indexes, boosting visibility for its cancer immunotherapy progress.
Elicio Therapeutics, a biotech company developing immunotherapies for KRAS-driven cancers, was added to the Russell 2000 and Russell 3000 indexes as of June 26, 2026. This inclusion marks a milestone reflecting growing recognition of Elicio's advance...
Orchestra BioMed joins Russell 3000 and Russell 2000 indexes, boosting visibility among investors.
Orchestra BioMed Holdings, a biomedical company, has been added to the Russell 3000 and Russell 2000 indexes following the 2026 Russell indexes reconstitution. This inclusion reflects the company's market capitalization ranking among the 4,000 larges...
Deadlines set for lead plaintiff appointments in class action lawsuits against Nano-X, Peabody Energy, and First Solar.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in class action lawsuits against Nano-X Imaging, Peabody Energy, and First Solar. These lawsuits allege misleading statements or omissions about operational efficien...
Deadlines near for lead plaintiff applications in shareholder lawsuits against GPK, IMMP, and PHR.
Holzer & Holzer, LLC announced upcoming deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. These lawsuits allege misleading stateme...
Deadlines near for lead plaintiff in class actions against BitGo, ADMA Biologics, and Erasca investors.
Law firm Holzer & Holzer, LLC has announced upcoming deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. These lawsuits allege that the companies made false or...
McEwen Inc. joins the Russell 2000 Index, boosting visibility among institutional investors.
McEwen Inc. has been added to the Russell 2000 Index as of June 29, 2026, following the Russell Reconstitution. This inclusion increases McEwen's visibility to institutional investors and index-tracking funds. The company focuses on gold, silver, and...